The long-term goal of this proposal is to identify molecular biological (gene) products that are associated with neuronal degeneration, and to discover new neuro-protective agents that can be used to prevent neuronal degeneration. This study is essential because neuronal losses are known to occur during aging; and sometimes they can lead to neurological disorders such as Alzheimer's disease. Mechanistic studies are difficult to perform in central nervous system in vivo, because it contains hetero- geneous cell populations. Differentiated murine neuroblastoma (NB) cells (adrenergic and cholinergic) spontaneously degenerate, and this process can be accelerated by neurotoxins such as glutamate and 6-hydroxydopamine (6-OHDA). Therefore, they can be useful models to study differentiation and degeneration of specific types of neurons.
The Specific Aims of this proposal are the following: a) to investigate the involvement of cell signaling pathways during differentiation of NB cells; b) to investigate the changes in cell signaling pathways during spontaneous and chemically-induced degeneration of differentiated adrenergic and cholinergic NB cells; c) to investigate the effect of vitamin E and ganglioside GM1 in prevention of spontaneous and chemically-induced degeneration of differentiated NB cells. Adrenergic clone NBA2(l), and cholinergic clone NBE-, will be used. Adenosine 3', 5'-cyclic monophosphate (cAMP) stimulating agents will be used to induce differentiation in the presence and absence of serum. 6-hydroxydopamine and glutamate will be used to induce rapid degeneration in differentiated NB cells. Alterations in signal transduction mechanisms represented by cAMP and diacylglycerol pathways will be determined. The parameters to be assayed include adenylate response to neurotransmitters, cAMP level, levels of protein kinase A (PKA) and PKC, and PKA- and PKC-dependent phosphorylation of proteins. The effects of vitamin E and ganglioside GM1 in preventing spontaneous and 6-OHDA- and glutamate-induced degeneration of differentiated adrenergic and cholinergic NB cells will be evaluated,using the same parameters. Future studies will focus on identification and characterization of gene products which are associated with neuronal degeneration and discovery of new neuroprotective agents.

Agency
National Institute of Health (NIH)
Institute
National Institute on Aging (NIA)
Type
First Independent Research Support & Transition (FIRST) Awards (R29)
Project #
1R29AG010869-01
Application #
3453644
Study Section
Neurology A Study Section (NEUA)
Project Start
1992-08-01
Project End
1997-06-30
Budget Start
1992-08-01
Budget End
1993-06-30
Support Year
1
Fiscal Year
1992
Total Cost
Indirect Cost
Name
University of Colorado Denver
Department
Type
Schools of Medicine
DUNS #
065391526
City
Aurora
State
CO
Country
United States
Zip Code
80045
Rockenstein, Edward; Mante, Michael; Alford, Michael et al. (2005) High beta-secretase activity elicits neurodegeneration in transgenic mice despite reductions in amyloid-beta levels: implications for the treatment of Alzheimer disease. J Biol Chem 280:32957-67
Song, David D; Shults, Clifford W; Sisk, Abbyann et al. (2004) Enhanced substantia nigra mitochondrial pathology in human alpha-synuclein transgenic mice after treatment with MPTP. Exp Neurol 186:158-72
Rockenstein, E; Adame, A; Mante, M et al. (2003) The neuroprotective effects of Cerebrolysin in a transgenic model of Alzheimer's disease are associated with improved behavioral performance. J Neural Transm 110:1313-27
Hashimoto, Makoto; Masliah, Eliezer (2003) Cycles of aberrant synaptic sprouting and neurodegeneration in Alzheimer's and dementia with Lewy bodies. Neurochem Res 28:1743-56
Kennedy, B P; Ziegler, M G; Alford, M et al. (2003) Early and persistent alterations in prefrontal cortex MAO A and B in Alzheimer's disease. J Neural Transm 110:789-801
Rockenstein, Edward; Mallory, Margaret; Hashimoto, Makoto et al. (2002) Differential neuropathological alterations in transgenic mice expressing alpha-synuclein from the platelet-derived growth factor and Thy-1 promoters. J Neurosci Res 68:568-78
Veinbergs, Isaac; Everson, Analisa; Sagara, Yutaka et al. (2002) Neurotoxic effects of apolipoprotein E4 are mediated via dysregulation of calcium homeostasis. J Neurosci Res 67:379-87
Wyss-Coray, Tony; Yan, Fengrong; Lin, Amy Hsiu-Ti et al. (2002) Prominent neurodegeneration and increased plaque formation in complement-inhibited Alzheimer's mice. Proc Natl Acad Sci U S A 99:10837-42
Rockenstein, E; Mallory, M; Mante, M et al. (2002) Effects of Cerebrolysin on amyloid-beta deposition in a transgenic model of Alzheimer's disease. J Neural Transm Suppl :327-36
Veinbergs, I; Van Uden, E; Mallory, M et al. (2001) Role of apolipoprotein E receptors in regulating the differential in vivo neurotrophic effects of apolipoprotein E. Exp Neurol 170:15-26

Showing the most recent 10 out of 32 publications